Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trial

Authors:

Abstract
No abstract available
Funding Information
  • Exelixis

This publication has 26 references indexed in Scilit: